(Q48455237)

11 February 2018

title

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder (English)

1 reference

11 February 2018

0 references

4

Wakako Umene-Nakano

1 reference

11 February 2018

Reiji Yoshimura

1

Reiji Yoshimura

1 reference

11 February 2018

Jun Nakamura

7

Jun Nakamura

1 reference

11 February 2018

Atsuko Ikenouchi-Sugita

3

Atsuko Ikenouchi-Sugita

1 reference

11 February 2018

Hikaru Hori

2

Hikaru Hori

1 reference

11 February 2018

Asuka Katsuki

5

Asuka Katsuki

1 reference

11 February 2018

Kiyokazu Atake

6

Kiyokazu Atake

1 reference

11 February 2018

publication date

30 June 2013

1 reference

11 February 2018

published in

Human Psychopharmacology

1 reference

11 February 2018

volume

28

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

page(s)

466-470

1 reference

11 February 2018

Passage of cytokines across the blood-brain barrier

cites work

1 reference

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment

21 January 2018

1 reference

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

Association of interleukin-6 and other biologic variables with depression in older people living in the community

21 January 2018

1 reference

A rating scale for depression

21 January 2018

1 reference

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis

21 January 2018

1 reference

Microglia as a source and target of cytokines

21 January 2018

1 reference

The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity

21 January 2018

1 reference

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity

21 January 2018

1 reference

Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.

21 January 2018

1 reference

Cytokines and the brain: implications for clinical psychiatry

21 January 2018

1 reference

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.

21 January 2018

1 reference

Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?

21 January 2018

1 reference

Reciprocal actions of interleukin-6 and brain-derived neurotrophic factor on rat and mouse primary sensory neurons.

21 January 2018

1 reference

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

21 January 2018

1 reference

Serotonin transporter gene, depressive symptoms, and interleukin-6.

21 January 2018

1 reference

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients

21 January 2018

1 reference

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression

21 January 2018

1 reference

Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HUP.2333

1 reference

11 February 2018

1 reference

11 February 2018